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Abstract
Background
Tissue hypoperfusion and inflammation in sepsis can lead to organ failure including kidney
and liver. In sepsis, mortality of acute kidney injury increases by more than 50%. Which
type of volume replacement should be used is still an ongoing debate. We investigated the
effect of different volume strategies on inflammatory mediators in kidney and liver in an
early sepsis model.
Material and Methods
Adult male Wistar rats were subjected to sepsis by cecal ligation and puncture (CLP) and
assigned to three fluid replenishment groups. Animals received 30mL/kg of Ringer’s lactate
(RL) for 2h, thereafter RL (75mL/kg), hydroxyethyl starch (HES) balanced (25mL/kg), con-
taining malate and acetate, or HES saline (25mL/kg) for another 2h. Kidney and liver tissue
was assessed for inflammation. In vitro rat endothelial cells were exposed to RL, HES bal-
anced or HES saline for 2h, followed by stimulation with tumor necrosis factor-α (TNF-α) for
another 4h. Alternatively, cells were exposed to malate, acetate or a mixture of malate and
acetate, reflecting the according concentration of these substances in HES balanced. Pro-
inflammatory cytokines were determined in cell supernatants.
Results
Cytokine mRNA in kidney and liver was increased in CLP animals treated with HES bal-
anced compared to RL, but not after application of HES saline. MCP-1 was 3.5fold (95% CI:
1.3, 5.6) (p<0.01) and TNF-α 2.3fold (95% CI: 1.2, 3.3) (p<0.001) upregulated in the kidney.
Corresponding results were seen in liver tissue. TNF-α-stimulated endothelial cells co-
exposed to RL expressed 3529±1040pg/mL MCP-1 and 59±23pg/mL CINC-1 protein.
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These cytokines increased by 2358pg/mL (95% CI: 1511, 3204) (p<0.001) and 29pg/ml
(95% CI: 14, 45) (p<0.01) respectively when exposed to HES balanced instead. However,
no further upregulation was observed with HES saline. PBS supplemented with acetate
increased MCP-1 by 1325pg/mL (95% CI: 741, 1909) (p<0.001) and CINC-1 by 24pg/mL
(95% CI: 9, 38) (p<0.01) compared to RL. Malate as well as HES saline did not affect cyto-
kine expression.
Conclusion
We identified HES balanced and specifically its component acetate as pro-inflammatory
factor. How important this additional inflammatory burden on kidney and liver function is
contributing to the sepsis-associated inflammatory burden in early sepsis needs further
evaluation.
Introduction
Sepsis remains a major worldwide healthcare problem with consistently high mortality. Acute
kidney injury (AKI) is a most prominent and severe complication of sepsis, occurring in 23%
to 51% of patients depending on the severity of the sepsis [1] and causing more than 50% of
the cases of AKI in patients treated in an ICU [2]. The pathophysiological understanding of
sepsis-associated AKI has evolved from a simplistic hypovolemia to more complex concepts
that better reflect the multifactorial nature of the condition. While sepsis-induced decrease in
global renal blood flow (RBF) plays a major role in the development of AKI, there is now evi-
dence that AKI may also occur under conditions of renal hyperperfusion [3]. However, hemo-
dynamic changes associated with low cardiac output leading to renal hypoperfusion and
ischemia-reperfusion injury do remain a major pathogenetic factor of sepsis-associated AKI.
Consequently, fluid resuscitation continues to be a mainstay of treatment in septic AKI, and
preservation of ‘physiological’ renal blood flow for prevention of further injury to the kidney
seems imperative even in the absence of ischemia as initial pathogenic factor. For fluid resusci-
tation the choice of fluid, however, has been a widely debated topic, with type, timing and
amount all being relevant factors potentially impacting on kidney function [4]. Synthetic and
natural colloids as well as crystalloids are the most commonly used types of fluids, however
adverse effects on the kidney attributed to hydroxyethyl starch (HES) preparations have been a
concern for considerable time [5]. This lead to the rationale of this work supposing that HES
could have a proinflammatory effect.
This study is specifically investigating potential differences in two different third-generation
HES preparations (HES 130/0.42/6% saline and HES 130/0.42/6% balanced solution) com-
pared to Ringer’s lactate (RL) for their pro-inflammatory potential in an early sepsis model in
rats. With the advancing understanding of the pathogenesis of sepsis-induced organ dysfunc-
tion the importance of inflammatory changes has been emphasized [6] and it is consequently
of considerable interest to identify a potential introduction of additional inflammatory changes
induced by the administration of treatments like HES preparations. The study compares the
effects of the two different HES preparations with RL on tissue expression of inflammatory
markers in kidney and liver as well as the urinary markers creatinine and α-microglobuline in
a cecal ligation and puncture (CLP) sepsis model in the rat. As the endothelium is the first
compartment exposed to inflammatory stimuli in sepsis, the inflammatory response of endo-
thelial cells exposed directly to the HES preparations was furthermore assessed in vitro using
rat endothelial cells.
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Materials and Methods
Animal experiment
The animal experiments and methods/ procedures applied have been approved and been in
accordance with the local animal care committee (Veterinäramt des Kantons Zürich), approval
number 132/2007.
Specific pathogen-free male Wistar rats (Charles River Laboratories, Germany) weighing
350g to 450g were used for the experiments. Animals were housed in standard cages at 22+/-
1°C under a 12/12h light/dark scheme. Food and water were available ad libitum.
For the induction of the sepsis rats were anesthetized using intraperitoneal ketamine
(100mg/kg body weight) and xylazine (5mg/kg body weight). After shaving and disinfecting
the lower quadrants of the abdomen a midline incision of approximately 4cm length was per-
formed. The cecum was identified and the corresponding mesenteric membrane dissected. A
cecal ligation was positioned consistently at the distal third, i.e. at 30–40% of the cecum. The
perforation of the cecum was performed using a 18G needle, first puncturing the anti-mesen-
teric side, then continuing the needle penetration through the lumen to the second perforation
on the mesenteric side. A small amount of fecal material was then gently extruded from both
perforation holes. After repositioning the cecum within the abdominal cavity the abdomen was
closed in two layers. Sham animals were treated in an identical fashion except from CLP.
Access for intravenous fluid resuscitation was obtained via a sterile 22G catheter (BD Insyte,
Becton Dickinson SA, Madrid, Spain) inserted into the tail vein of the animals. Animals were
monitored continuously and were kept at 37°C. Anesthesia/sedation was maintained by
repeated subcutaneous administration of ketamine and xylazine (25mg/kg and 1.25mg/kg
body weight) every 45min. Ketamine is a well known analgesic in order to minimize suffering
of the animals.
Fluid resuscitation was performed using the following preparations and according to the fol-
lowing regimen: Ringer’s lactate (RL–Ringerlactat, B. Braun), HES 130/0.42/6% saline (HES
saline—Venofundin 6%, B. Braun) or HES 130/0.42/6% balanced solution (HES balanced—
Tetraspan 6%, B. Braun). The carrier solution of HES products is an electrolyte solution in case
of HES saline it is normal saline, in case of HES balanced a balanced electrolyte solution con-
taining apart form sodium, chloride, calcium, potassium, magnesium, acetate and malate. All
animals received RL one hour after the procedure at a volume of 30mL/kg i.v. Two hours after
the procedure, animals received either RL at a volume of 75mL/kg, HES saline or HES balanced
at a volume of 25mL/kg.
The animals were sacrificed after 4h while under deep anesthesia with ketamine/xylazine.
They were exsanguinated (by incising the abdominal aorta and inferior vena cava) and the
heart was flushed with ice cold phosphate buffered saline (PBS), kidneys and liver were excised,
snap-frozen in liquid nitrogen and stored at -80°C for RNA extraction.
At least 4 animals were included in each sham group and 9 in each CLP arm of the study.
The detailed experimental setup is displayed in Fig 1A.
In vitro experiment
Rat pulmonary artery endothelial cells, a gift from Dr. Roscoe Warner (Assistant professor,
Department of Pathology, University of Michigan at Ann Arbor, Ann Arbor, MI; Head: Dr.
Peter A. Ward) [7, 8] were grown at 37°C in Dulbeco’s Eagle Medium (DMEM) completed
with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, all from GIBCO, Carlsbad, CA). Confluent cells were
incubated over night in starving medium containing 1% FBS. The next morning, cells were
Inflammatory Kidney and Liver Tissue Response to Different HES Preparations in Sepsis
PLOS ONE | DOI:10.1371/journal.pone.0151903 March 17, 2016 3 / 15
exposed to a 1:1 dilution of medium and either RL, HES saline or HES balanced, respectively.
After a 2h the incubation solution was replaced by the same solution, completed with 0.5ng/
Fig 1. Experimental setting. Fig 1A gives an overview of the experimental animal setting and time line, Fig 1B displays the in vitro setup.
doi:10.1371/journal.pone.0151903.g001
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mL tumor necrosis factor-α (TNF-α, BD Pharmingen, San Diego, CA). Control cells were
exposed to phosphate-buffered saline only. After 6h cell supernatants were harvested and
stored at -20°C for further analysis.
An analogue experiment was performed to determine the impact of the respective composi-
tion of the HES preparations (saline only or addition of malate and/or acetate). Ringer’s lactate
was the reference volume replacement. Concentrations used were 24mmol sodium acetate,
5mmol sodium malate or a mixture of 24mmol sodium acetate plus 5mmol sodium malate.
The amount of acetate and malate was chosen according to the concentrations of acetate and
malate in HES balanced. An overview of the experimental setting is given in Fig 1B.
Assessment of inflammation using enzyme-linked immunosorbent
assay (ELISA) and real time polymerase chain reaction (PCR)
To be able to compare our results with other animal studies focusing on systemic or inflamma-
tory processes we decided to focus on inflammatory mediators. Furthermore, determination of
these markers allowed us to differentiate between systemic effects and inflammatory scenarios
in the various tissues, where the cytokines are expressed as well. This aspect of compartmentali-
zation seems to be essential.
Expression of MCP-1, CINC-1, TNF-α and intercellular adhesion molecule-1 (ICAM-1)
mRNA was determined in kidney and liver tissue by real-time PCR. Tissue was homogenized
using MagNA Lyser Green Beads (Roche Diagnostics, Basel, CH) and a Precellys Homogenizer
for 1x30sec at 6800rpm. Total RNA was purified using the RNeasy mini Kit (Qiagen AG, Hom-
brechtikon, CH). 0.5μg RNA was used for reverse transcription using the Taqman Reverse
Transcription Kit (ABI, Life Technogolies, CH). Quantitative PCR was performed using the
PCR Probe Mastermix and labeled probes (both from Roche) and primers (Microsynth, Bal-
gach, CH), designed for MCP-1, CINC-1, TNF-α, ICAM-1 and the housekeeping gene 18S.
The final reaction volume was 15μl using a Gene Amp 5700 System (ABI, Life Technologies,
CH). The comparative Ct method was used for quantification of the gene expression. Ct values
of the samples were normalized to 18S.
The cytokines monocyte chemoattractant protein-1 (MCP-1) and cytokine-induced neutro-
phil chemoattractant-1 (CINC-1) in cell supernatants were determined by sandwich ELISA
technique according the manufacturer’s protocol (both from R&D Systems, Abingdon, UK).
Creatinine and α-microglobulin determination
Creatinine was assessed using a DriChem 4000i Analyzer (Fuji Film, Tokio, Japan) and the cor-
responding DriChem slides (Fuji) according the manufacturer’s instruction.
Alpha-microglobulin determination took place by an ELISA-kit according the manufactur-
er’s protocol (Hölzel Diagnostika, Cologne, Germany).
Statistical analysis
Statistical analysis was performed using R, Version 3.2.2 (R Development Core Team, 2015),
with the packages lme4 [9], lmerTest [10], and ggplot2 [11]. Linear mixed model analyses were
used to assess the influence on tissue inflammatory mediator expression by the different types
of treatment. Exposure to RL has been defined as the reference category. The tabular results
show coefficients and corresponding 95% confidence intervals of the mixed models. Figures
illustrate boxplots with medians and quartiles. Whiskers represent 5% and 95% confidence
intervals. A p-value<0.05 was considered significant.
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Results
With the aim to study a potential treatment-associated inflammatory effect in very early stages
of AKI the present short-term model of CLP was chosen. Correspondingly, mild but consistent
increases in inflammatory markers were observed in the CLP RL-treated compared to sham-
operated RL-treated animals. In the kidney, MCP-1 and CINC-1 expression increased by a 2.8-
and 3.5-fold compared to sham-operated animals (both p<0.01, Table 1. This was less pro-
nounced for TNF-α levels in CLP animals (1.4-fold increase, p<0.01). Intercellular adhesion
molecule-1 was not significantly more expressed in CLP than in sham animals.
The inflammatory response of CLP compared to sham animals was similarly observed in
liver tissue: a 51.7-fold increase of MCP-1 was seen in the liver of CLP animals (Table 2). The
CLP procedure had a marginal effect on CINC-1 mRNA expression (upregulation by a
0.6-fold, p<0.05) and no quantifiable effect on TNF-α and ICAM-1 levels.
This early phase-CLP model resulted in a mild consistent inflammatory tissue response in
kidney and liver corresponding to early systemic changes as a consequence of the local intra-
abdominal inflammatory process. It is noteworthy that despite this relatively mild inflamma-
tion the sensitivity of the model was sufficiently high to distinguish different degrees of inflam-
matory reactions to the various volume repletion treatments.
Table 1. Influence of CLP and different fluid resuscitation procedures on inflammatory mediator expression (mRNA) in kidneys.
Dependent variables Independent variables R2
CLP HES balanced HES saline
MCP-1, fold change 2.8 (0.7, 4.8) 2 3.5 (1.3, 5.6) 2 -0.2 (-2.4, 1.9) 0.329
CINC-1, fold change 3.5 (1.1, 5.8) 2 1.8 (-0.6, 4.3) 0.6 (-1.69, 2.9) 0.201
TNF-α, fold change 1.4 (0.4, 2.4) 2 2.3 (1.2, 3.3) 1 -0.3 (-1.2, 0.7) 0.415
ICAM-1, fold change 1.2 (0.2, 2.2) 3 2.2 (1.2, 3.2) 1 -0.7 (-1.0, 0.9) 0.394
Exposure to Ringer’s lactate solution has been deﬁned as the reference group in the mixed model. The table shows coefﬁcients with corresponding 95%
conﬁdence intervals. CINC-1: cytokine-induced neutrophil chemoattractant 1; CLP: cecal ligation and puncture; HES: hydroxyethyl starch; ICAM-1:
intercellular adhesion molecule-1; MCP-1: monocyte chemotactic protein 1; TNF-α: tumor necrosis factor-α.
1 p .001
2 p .01
3 p .05.
doi:10.1371/journal.pone.0151903.t001
Table 2. Influence of CLP and different fluid resuscitation procedures on inflammatory mediator expression (mRNA) in the liver.
Dependent variables Independent variables R2
CLP HES balanced HES saline
MCP-1, fold change 51.7 (3.5, 99.9) 3 118.7 (63.8, 173.5) 1 -5.0 (-53.5, 43.5) 0.268
CINC-1, fold change 0.63 (0.1, 1.2) 3 0.6 (0.0, 1.3) -0.5 (-1.1, 0.1) 0.428
TNF-α, fold change 49.9 (-26.7, 126.6) 134.4 (47.2, 221.6) 2 -6.4 (-83.4, 70.8) 0.344
ICAM-1, fold change 196.8 (-52.1, 445.7) 512.3 (229.7, 795.0) 1 -24.5 (-278.0, 229.0) 0.295
Exposure to Ringer’s lactate solution has been deﬁned as the reference group in the mixed model. The table shows coefﬁcients with corresponding 95%
conﬁdence intervals. CINC-1: cytokine-induced neutrophil chemoattractant 1; CLP: cecal ligation and puncture; HES: hydroxyethyl starch; ICAM-1:
intercellular adhesion molecule-1; MCP-1: monocyte chemotactic protein 1; TNF-α: tumor necrosis factor-α.
1 p  .001
2 p  .01
3 p  .05.
doi:10.1371/journal.pone.0151903.t002
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Different inflammatory response to various fluid resuscitation treatments
in the kidney
In CLP animals expression of inflammatory mediators upon administration of HES saline was
similar to animals treated with RL. In contrast, administration of HES balanced led to an addi-
tional 3.5-fold increase of MCP-1 (p< 0.01), a 2.3-fold increase of TNF-α (p<0.001) and a
2.2-fold increase of ICAM-1 (p 0.001) (Table 1, Fig 2).
Fig 2. Inflammatory mediator expression (mRNA) in kidney tissue. Relative mRNA levels of the inflammatory cytokines MCP-1 (Fig 2A), CINC-1 (Fig
2B), TNF-α (Fig 2C), and ICAM-1 (Fig 2D) are shown. Results are presented as boxplot figures with medians and quartiles. Whiskers represent 5% and 95%
confidence intervals.
doi:10.1371/journal.pone.0151903.g002
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In order to further evaluate a possible impact of the administration of different HES prepa-
rations on kidney function creatinine and α-microglobuline levels in the urine were measured
(Table 3, Fig 3). In rats undergoing CLP creatinine increased by 1.23mg/dL, (p<0.01) and α-
microglobuline by 11μg/mL (p<0.05) compared to sham-operated animals. A significant influ-
ence of the different fluid resuscitation regimens was not apparent.
The inflammatory response to different fluid resuscitation treatments in
the liver
Cecal ligation and puncture animals showed a significant increase in hepatic mRNA expression
of MCP-1 by 118.7-fold (p<0.001), of TNF-α by 134.4-fold (p<0.01), and of ICAM-1 by a
512.3-fold (p<0.001) when treated with HES balanced compared to CLP animals with applica-
tion of RL (Table 3, Fig 4). This difference was not seen when animals were given HES saline.
Overall and similar to the results in kidney tissue, the exposure to HES balanced resulted in an
accentuation of the inflammatory response in septic animals.
Table 3. Influence of different fluid resuscitation procedures on excretion of creatinine and α-microglobuline in urine.
Dependent variables Independent variables R2
CLP HES balanced HES saline
Creatinine, mg/dL 1.23 (0.47, 1.98) 1 0.56 (-0.47, 1.59) -0.03 (-0.84, 0.78) 0.143
α-microglobuline, μg/mL 11 (3, 20) 1 -3 (-14, 8) -5 (-15, 4) 0.234
Exposure to Ringer’s lactate solution has been deﬁned as the reference group in the mixed model. CLP: cecal ligation and puncture; HES: hydroxyethyl
starch. The table shows coefﬁcients with corresponding 95% conﬁdence intervals.
1 p  .01.
doi:10.1371/journal.pone.0151903.t003
Fig 3. Creatinine and α-microglobuline concentration in urine. Kidney function was assessed by creatinine (Fig 3A) and α-microglobuline (Fig 3B).
Results are presented as boxplot figures with medians and quartiles. Whiskers represent 5% and 95% confidence intervals.
doi:10.1371/journal.pone.0151903.g003
Inflammatory Kidney and Liver Tissue Response to Different HES Preparations in Sepsis
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Determination of the inflammation-triggering component of volume
repletion treatment with HES balanced in vitro
The in vivo results demonstrating a significantly increased inflammatory response in both kid-
ney and liver tissue of animals with HES balanced volume resuscitation in an early septic con-
dition raised the question about a potentially causative component of the HES balanced
volume repletion treatment. For further exploration, the in vivo model was thus translated into
Fig 4. Inflammatory mediator expression (mRNA) in liver tissue. Relative mRNA levels of the inflammatory cytokines MCP-1 (Fig 4A), CINC-1 (Fig 4B),
TNF-α (Fig 4C) and ICAM-1 (Fig 4D) are shown. Results are presented as boxplot figures with medians and quartiles. Whiskers represent 5% and 95%
confidence intervals.
doi:10.1371/journal.pone.0151903.g004
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an in vitromodel of endothelial inflammation for a detailed examination. In analogy to the ani-
mal experiments, an inflammatory response in endothelial cells was induced by stimulation
with TNF-α, and expression levels of MCP-1 and CINC-1 were assessed. Cells exposed to
TNF-α and RL expressed 3529±1040pg/mL MCP-1 and 59±23pg/mL CINC-1 protein. As
illustrated in Table 4 exposure to HES balanced increased the secretion of inflammatory medi-
ators in TNF-α-stimulated endothelial cells by an additional 2358pg/mL for MCP-1 (p<0.001)
(Fig 5A) and an additional 29pg/mL for CINC-1 (p<0.01) (Fig 5B). The levels of MCP-1 and
CINC-1 were not significantly affected by HES saline in TNF-α-stimulated endothelial cells
(Table 4).
In order to further characterize a potential association with the electrolyte composition of
the volume resuscitation treatments the cells were either exposed to RL or to PBS with or with-
out addition of acetate and/or malate. Exposure to HES balanced or acetate, resulted in higher
MCP-1 concentrations in the supernatants of the endothelial cells. Compared to cells exposed
to TNF-α and RL, mean MCP-1 levels were elevated by 842pg/mL after incubation with HES
balanced (p<0.01, Fig 5A) and by 1059pg/mL after exposure to acetate-containing PBS
(p<0.01, Fig 5C). No significant effect on MCP-1 secretion was observed after incubation with
HES saline or malate in endothelial cells (Table 5). Consistent with the results for MCP-1, HES
balanced further increased CINC-1 expression by 29pg/mL (p<0.01), acetate by 21pg/mL
(p<0.01) compared to RL (Fig 5D).
Discussion
In summary our in vivo results show increased levels of inflammation for the cecal ligation and
puncture model. This was uninfluenced by RL and HES saline, but was further accentuated by
HES balanced.
Similar observations could be made in endothelial cells in vitro: TNF-α induced an inflam-
mation in rat endothelial cells, which was uninfluenced by HES saline, but was even more
accentuated in the presence of HES balanced. Testing the solution’s electrolyte composition,
acetate in the concentration found in HES balanced lead to a more pronounced inflammation
while malate did not.
Sepsis remains a major worldwide healthcare problem with consistently high mortality. The
condition can be generally described as the occurrence of an infection together with a systemic
response to and manifestation of the infection [12]. The body’s systemic response to a patho-
gen may result in conditions of various levels of severity that have been categorized in three
stages [12, 13]: sepsis, severe sepsis and septic shock. Sepsis is characterized by a Systemic
Inflammatory Response Syndrome (SIRS), the presence of at least 2 out of its 4 defining criteria
and a proven or suspected infection. Severe sepsis further comprises sepsis-induced organ
Table 4. Influence of different fluid solutions inflammatorymediator secretion (protein) of rat endothe-
lial cells.
Ingredients HES balanced HES saline R2
MCP-1, pg/mL 2358 (1511, 3204) 1 1003 (156, 1850) 0.329
CINC-1, pg/mL 29 (14, 45) 2 12 (-3, 28) 0.235
Exposure to Ringer’s lactate solution has been deﬁned as the reference group in the mixed models. The
table shows coefﬁcients with corresponding 95% conﬁdence intervals. CINC-1: cytokine-induced neutrophil
chemoattractant-1; HES: hydroxyethyl starch; MCP-1: monocyte chemotactic protein-1.
1 p  .001
2 p  .01.
doi:10.1371/journal.pone.0151903.t004
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dysfunction or tissue hypoperfusion characterized by e.g. elevated lactate, oliguria or hypoten-
sion. Septic shock represents the most severe stage with persistent hypotension and multi-
organ dysfunction and failure. Pathophysiologically, sepsis is understood as a syndrome char-
acterized by complex series of events with immune system activation resulting in pro- and
anti-inflammatory reactions, humoral and cellular responses, abnormalities in microcircula-
tion predisposing to impaired general oxygen delivery, tissue hypoxia, multiorgan dysfunction
and ultimately death [14, 15].
Fig 5. Inflammatory response of rat pulmonary endothelial cells to fluid formulations or components and subsequent stimulation. Levels of the
inflammatory cytokines MCP-1 (Fig 5A and 5B) and CINC-1 (Fig 5C and 5D) after exposure to fluid formulations (RL, HES balanced and HES saline, Fig 5A
and 5C) and anions present in balanced solutions (5B and 5D). Results are presented as boxplot figures with medians and quartiles. Whiskers represent 5%
and 95% confidence intervals.
doi:10.1371/journal.pone.0151903.g005
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Sepsis-induced organ dysfunction and failure are most severe progression steps of the initial
systemic inflammatory response and usually the cause of death when severe sepsis and shock
are present. Target organs include the lungs, kidneys and liver. Sepsis-associated AKI reaches a
mortality of 70% compared to a 45% mortality rate in AKI alone [1] and thus constitutes a
severe medical problem.
The specific mechanisms leading to organ failure in sepsis and also the varying degree of
vulnerability of different organs are still not well understood. The systemic inflammatory
response, tissue hypoperfusion associated with hypotension[16, 17] and disseminated intravas-
cular coagulation (DIC) [18] seem to represent the major causative elements leading to organ
dysfunction [18].
The benefit-risk profile of fluid resuscitation as therapeutic intervention might be associated
with an inflammatory response in itself and may thus represent a potentially aggravating factor
in the development of the complex pathophysiologic situation in sepsis.
The reported safety profile of HES preparations has been characterized by adverse effects
predominantly on the coagulation system and renal function [19]. HES preparations have seen
development with decreasing molecular weights and molar substitution to arrive at the current
third generation preparations in order to improve their benefit-risk profile with reduced
adverse effects on these two organ systems. The initially higher molecular weight was aiming at
particularly long residence time in the circulation, an effect that receives less emphasis today in
favor of better pharmacodynamic control and potentially reduced adverse effects.
The inflammatory response to tissue injury has been a main research focus of the authors,
in particular in the lung [20–23]. In the present study, the research question centered on
inflammatory changes in an early in vivo sepsis model induced by cecal ligation and puncture
and investigating kidney and liver tissue following various forms of fluid resuscitation as a hall-
mark of sepsis treatment in order to improve hypotension and associated organ hypoperfusion.
As a secondary question the hypothesized inflammatory response differences to the various
fluid resuscitation regimens were to be analyzed for a potential association with distinct fluid
components. An in vitromodel of endothelial inflammation was chosen to discern differences
in the inflammatory response to the administration of different components.
We found a significantly more pronounced inflammatory mediator expression in animals
treated with HES balanced compared to those receiving HES saline or RL lactate. This effect
could be successfully transferred, reproduced and further analyzed in vitro in a model of
inflamed rat endothelial cells. Our analysis revealed that acetate but not malate or HES saline
are associated with an increased expression of inflammatory mediators.
There is a still on-going debate about the use of colloids in critically ill patients: concerns
have been raised with regard to possible adverse outcomes in patients receiving HES solutions,
Table 5. Influence of specific solution components on inflammatory mediator secretion of rat endo-
thelial cells.
Ingredients Acetate Malate R2
MCP-1, pg/mL 1325 (741, 1909) 1 291 (-293, 875) 0.199
CINC-1, pg/mL 24 (9, 38) 2 0 (-14, 15) 0.143
Exposure to Ringer’s lactate solution has been deﬁned as the reference group in the mixed model. The
table shows coefﬁcients with corresponding 95% conﬁdence intervals. CINC-1: cytokine-induced neutrophil
chemoattractant 1; MCP-1: monocyte chemotactic protein 1.
1 p  .001
2 p  .01.
doi:10.1371/journal.pone.0151903.t005
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especially in septic patients [24–26] and even a withdrawal of the marketing authorization for
HES has been demanded [27]. However, HES continues to be widely used for intravascular vol-
ume maintenance or augmentation in daily clinical routine [28]. In contrast to septic patients,
no differences in the incidence of death or acute kidney failure has been found in surgical and
trauma patients receiving 6% HES [29], for which reason a more nuanced view on the use of
HES solutions has been proposed [30].
In this model of CLP-induced septic peritonitis in rats, the research focus was on the very
early expression of prognostic inflammatory mediators impacting on severity and outcome of
sepsis [31, 32]. No effect of HES was observed on inflammatory mediator expression in kidney
and liver tissue. Interestingly a clear difference between HES balanced and HES saline has been
found. HES balanced provoked a significantly more pronounced expression of inflammatory
mediators compared with HES saline. This is in line with results from an earlier study investi-
gating the effects of balanced and non-balanced colloids in acute endotoxemia [23]. In the
same study, it has been hypothesized that balanced solutions containing acetate and malate
could be specifically associated with conditions of severe inflammation. The present data now
provides further experimental evidence that in particular acetate appears to be associated with
an aggravation of the inflammatory response. This observation is corroborated by data show-
ing other pro-inflammatory and also myocardial depressant and hypoxemia promoting char-
acteristics [33–35] induced by acetate which led for example to the discontinuation of its use in
fluids for renal replacement therapy.
Functional renal testing does not support our findings on the level of inflammatory media-
tors. This is likely due to the fact that inflammation-induced functional impairment in organs
is observed at a much later time point. We tried to differentiate between an inflammatory pro-
cess, which is induced by application of the balanced solution, and a possible inflammatory-
toxic effect, which might be seen immediately in changes in creatinine and alpha-microglobu-
lin values.
Strengths and limitations of the experimental approach.Our experimental approach has
several strengths starting with the use of an early stage in vivo model of polymicrobial sepsis. In
addition to confirming previous results in a different sepsis model [23], we do not only investi-
gate differences in the inflammatory response to several fluid resuscitation solutions in vivo
but furthermore also identify individual components associated with the stronger inflamma-
tory response to HES balanced in our in vitro approach. A certain limitation of the study might
is that this–like all models—represents a simplification of a scenario in the patient. This how-
ever allows discriminating factors impacting on a certain diseases in smaller study groups.
Conclusions and outlook. The data presented in this experimental study indicate that not
HES balanced per se but specifically acetate in HES balanced is a component contributing to a
more pronounced inflammatory response to the administration of HES balanced in an early
sepsis model. This additional pro-inflammatory element could potentially add to the overall
burden of the local and systemic inflammatory response in sepsis and therefore may impact
negatively on the course of the disease.
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